// App-Quantinova.ai

431 : Success of blinding a procedural intervention from treating clinicians in a randomised controlled trial (RCT) in preterm infants with respiratory distress syndrome

Researchers

Presenter

  • Peter A. Dargaville

Principal Investigators

  • Elizabeth Reid

  • C.Omar O. Kamlin

  • Francesca Orsini

  • Antonio De Paoli

  • Howard W. Clark

  • Roger F. Soll

  • John B. Carlin

  • Peter G. Davis

Medical Centers

  • Menzies Institute for Medical Research, Hobart, Tasmania, Australia

  • Murdoch Children's Research Institute & University of Melbourne, Melbourne, Victoria, Australia

  • MCRI, Melbourne, Victoria, Australia

  • Robert Larner, M.D., College of Medicine at the University of Vermont, Hinesburg, VT, United States

  • University College London, London, England, United Kingdom

  • Royal Hobart Hospital, Hobart, Tasmania, Australia

  • Royal Women's Hospital, Melbourne, Victoria, Australia

  • University of Melbourne, Melbourne, Victoria, Australia

Locations

  • Australia

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Infant Respiratory Distress Syndrome

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved